Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Press

Showing results (191-200 of 272) with videos related to

Pageof 28
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133Patricia A Ganz, Carol M Moinpour, Donna K Pauler, et al.
Haematologica|February 24, 2018
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohortLisa M Rimsza, Hongli Li, Rita M Braziel, et al.
Plos One|December 21, 2013
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphomaLihua E Budde, Carolina Berger, Yukang Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group StudyJ W Sweetenham, B Goldman, M L LeBlanc, et al.
Blood|February 26, 2005
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomabJohn M Bennett, Mark S Kaminski, John P Leonard, et al.
British Journal of Haematology|April 23, 2014
R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433Jonathan W Friedberg, Joseph M Unger, W Richard Burack, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell LymphomaYolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodiesEneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk LymphomaRyan D Cassaday, Oliver W Press, John M Pagel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 28, 2017
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture ConditionsSang Yun Lee, Philip Olsen, Dong Hoon Lee, et al.
Pageof 28

Showing results (191-200 of 272) with videos related to

Sort By:
Pageof 28
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133Patricia A Ganz, Carol M Moinpour, Donna K Pauler, et al.
Haematologica|February 24, 2018
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohortLisa M Rimsza, Hongli Li, Rita M Braziel, et al.
Plos One|December 21, 2013
Combining a CD20 chimeric antigen receptor and an inducible caspase 9 suicide switch to improve the efficacy and safety of T cell adoptive immunotherapy for lymphomaLihua E Budde, Carolina Berger, Yukang Lin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2009
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: a Southwest Oncology Group StudyJ W Sweetenham, B Goldman, M L LeBlanc, et al.
Blood|February 26, 2005
Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomabJohn M Bennett, Mark S Kaminski, John P Leonard, et al.
British Journal of Haematology|April 23, 2014
R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433Jonathan W Friedberg, Joseph M Unger, W Richard Burack, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell LymphomaYolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 6, 2008
Extracorporeal adsorption therapy: a method to improve targeted radiation delivered by radiometal-labeled monoclonal antibodiesEneida R Nemecek, Damian J Green, Darrell R Fisher, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2019
Phase I Study of a CD45-Targeted Antibody-Radionuclide Conjugate for High-Risk LymphomaRyan D Cassaday, Oliver W Press, John M Pagel, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 28, 2017
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture ConditionsSang Yun Lee, Philip Olsen, Dong Hoon Lee, et al.
Pageof 28